Corcept Therapeutics | CORT - Ebit

Stock Price
34.82
Daily Change
0.58 1.69%
Monthly
-4.10%
Yearly
-45.20%
Q1 Forecast
33.74

Corcept Therapeutics reported $10.22M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Acadia Pharmaceuticals USD 35.76M 3.38M Sep/2025
Alaunos Therapeutics USD -1.19M 148K Sep/2025
ANI Pharmaceuticals USD 22.83M 7.66M Sep/2025
Ardelyx USD 7.12M 19.62M Sep/2025
Aurora Cannabis CAD -44.75M 27.14M Sep/2025
BioMarin Pharmaceutical USD -31.69M 308.58M Sep/2025
Bristol-Myers Squibb USD 3.47B 567M Dec/2025
Canopy Growth CAD -14.3M 17.19M Sep/2025
Corcept Therapeutics USD 10.22M 16.46M Sep/2025
Eli Lilly USD 8.99B 1.57B Dec/2025
Esperion Therapeutics USD -16.03M 11.51M Sep/2024
J&J USD 5.11B 2.3B Dec/2025
Knight Therapeutics CAD 3.2M 1.29M Sep/2024
Lexicon Pharmaceuticals USD -49.63M 5.39M Sep/2023
Merck USD 6.24B 1.32B Dec/2025
Nektar Therapeutics USD -34.34M 3.68M Sep/2024
Novartis USD -9.19B 13.87B Jun/2025
Novartis USD 4.48B 343M Sep/2025
Omeros USD -48.15M 7.25M Sep/2023
Pacira USD 13.15M 2.92M Sep/2025
Pfizer USD 4.65B 71M Dec/2025
Supernus Pharmaceuticals USD -60.18M 72.33M Sep/2025
TG Therapeutics USD 29.36M 5.48M Sep/2025